BDNF and depressive symptom measurement: Rb1 downregulates miR-134 expression, thereby relieves miR-134-mediated suppression of BDNF, activates BDNF-TrkB signaling pathway, enhances synaptic plasticity, and ultimately ameliorates depression-like behaviors (Wang et al., 2022).